Back to Trades
Patel Samir Rashmikant
DirectorCIK 0001702447
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Across 3 filings between 2025–2026, Patel Samir Rashmikant, Director, has disclosed $772.6K in transactions — all concentrated in Akari Therapeutics Plc (AKTX). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Oct 16 | AKTX Akari Therapeutics Plc | Patel Samir Rashmikant | Director | Grant | $67.4K |
| Jul 17 | AKTX Akari Therapeutics Plc | Patel Samir Rashmikant | Director, 10% Owner | Exercise | $19.4K |
| Dec 18 | AKTX Akari Therapeutics Plc | Patel Samir Rashmikant | Director, 10% Owner | Other | $330.3K |
3 filings